Markers of bacteremia in febrile neutropenic patients with hematological malignancies: Procalcitonin and IL-6 are more reliable than C-reactive protein

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 23, Issue 7, 2004, Pages 539-544

  Von Lilienfeld Toal, M ^a   Dietrich, M P ^a   Glasmacher, A ^a   Lehmann, L ^a   Breig, P ^a   Hahn, C ^a   Schmidt Wolf, I G H ^a   Marklein, G ^a   Schroeder, S ^a   Stuber, F ^a  

^a UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 6; PROCALCITONIN;

ADULT; AGED; ARTICLE; BACTEREMIA; BLOOD CULTURE; CONCENTRATION (PARAMETERS); DIAGNOSTIC ACCURACY; DISEASE MARKER; FEBRILE NEUTROPENIA; FEMALE; HEMATOLOGIC MALIGNANCY; HORMONE BLOOD LEVEL; HORMONE DETERMINATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PNEUMONIA; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PYREXIA IDIOPATHICA; RANK SUM TEST;

ADULT; AGED; ANALYSIS OF VARIANCE; BACTEREMIA; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CALCITONIN; CHI-SQUARE DISTRIBUTION; COHORT STUDIES; FEMALE; FEVER; GRAM-NEGATIVE BACTERIAL INFECTIONS; GRAM-POSITIVE BACTERIAL INFECTIONS; HEMATOLOGIC NEOPLASMS; HUMANS; INTERLEUKIN-6; MALE; MIDDLE AGED; NEUTROPENIA; PREDICTIVE VALUE OF TESTS; PROBABILITY; PROGNOSIS; PROTEIN PRECURSORS; RISK ASSESSMENT; ROC CURVE; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC;

EID: 3442876758     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Buchheidt D, Bohme A, Comely OA, Fatkenheuer G, Fuhr HG, Heussel G, Junghanss C, Karthaus M, Kellner O, Kern WV, Schiel X, Sezer O, Sudhoff T, Szelenyi H (2003) Diagnosis and treatment of documented infections in neutropenic patients - recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO). Ann Hematol 82(Suppl 2):127-132
2. Link H, Bohme A, Comely OA, Hoffken K, Kellner O, Kern WV, Mahlberg R, Maschmeyer G, Nowrousian MR, Ostermann H, Ruhnke M, Sezer O, Schiel X, Wilhelm M, Auner HW (2003) Antimicrobial therapy of unexplained fever in neutropenic patients - guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO), Study Group Interventional Therapy of Unexplained Fever, Arbeitsgemeinschaft Supportivmassnahmen in der Onkologie (ASO) of the Deutsche Krebsgesellschaft (DKG-German Cancer Society). Ann Hematol 82(Suppl 2):105-117
3. Sudhoff T, Giagounidis A, Karthaus M (2000) Serum and plasma parameters in clinical evaluation of neutropenic fever. Antibiot Chemother 50:10-19
4. Engervall P, Granstrom M, Andersson B, Bjorkholm M (1995) Monitoring of endotoxin, interleukin-6 and C-reactive protein serum concentrations in neutropenic patients with fever. Eur J Haematol 54:226-234
5. Abrahamsson J, Pahlman M, Mellander L (1997) Interleukin 6, but not tumour necrosis factor-alpha, is a good predictor of severe infection in febrile neutropenic and non-neutropenic children with malignancy. Acta Paediatr 86:1059-1064
6. Engel A, Mack E, Kern P, Kern WV (1998) An analysis of interleukin-8, interleukin-6 and C-reactive protein serum concentrations to predict fever, gram-negative bacteremia and complicated infection in neutropenic cancer patients. Infection 26:213-221
7. Heney D, Lewis IJ, Evans SW, Banks R, Bailey CC, Whicher JT (1992) Interleukin-6 and its relationship to C-reactive protein and fever in children with febrile neutropenia. J Infect Dis 165:886-890
8. Oberhoffer M, Stonans I, Russwurm S, Stonane E, Vogelsang H, Junker U, Jager L, Reinhart K (1999) Procalcitonin expression in human peripheral blood mononuclear cells and its modulation by lipopolysaccharides and sepsis-related cytokines in vitro. J Lab Clin Med 134:49-55
9. Meisner M, Muller V, Khakpour Z, Toegel E, Redl H (2003) Induction of procalcitonin and proinflammatory cytokines in an anhepatic baboon endotoxin shock model. Shock 19:187-190
10. Assicot M, Gendrel D, Carsin H, Raymond J, Guilbaud J, Bohuon C (1993) High serum procalcitonin concentrations in patients with sepsis and infection. Lancet 341:515-518
11. Chirouze C, Schuhmacher H, Rabaud C, Gil H, Khayat N, Estavoyer JM, May T, Hoen B (2002) Low serum procalcitonin level accurately predicts the absence of bacteremia in adult patients with acute fever. Clin Infect Dis 35:156-161
12. Svaldi M, Hirber J, Lanthaler AI, Mayr O, Faes S, Peer E, Mitterer M (2001) Procalcitonin-reduced sensitivity and specificity in heavily leucopenic and immunosuppressed patients. Br J Haematol 115:53-57
13. Engel A, Steinbach G, Kern P, Kern WV (1999) Diagnostic value of procalcitonin serum levels in neutropenic patients with fever: comparison with interleukin-8. Scand J Infect Dis 31:185-189
14. Fleischhack G, Kambeck I, Cipic D, Kasan C, Bode U (2000) Procalcitonin in paediatric cancer patients: its diagnostic relevance is superior to that of C-reactive protein, interleukin 6, interleukin 8, soluble interleukin 2 receptor and soluble tumour necrosis factor receptor II. Br J Haematol 111:1093-1102
15. Giamarellos-Bourboulis EJ, Grecka P, Poulakou G, Anargyrou K, Katsilambros N, Giamarellou H (2001) Assessment of procalcitonin as a diagnostic marker of underlying infection in patients with febrile neutropenia. Clin Infect Dis 32:1718-1725
16. Bernard L, Fernere F, Casassus P, Malas F, Leveque S, Guillevin L, Lortholary O (1998) Procalcitonin as an early marker of bacterial infection in severely neutropenic febrile adults. Clin Infect Dis 27:914-915
17. Schuttrumpf S, Binder L, Hagemann T, Berkovic D, Trumper L, Binder C (2003) Procalcitonin: a useful discriminator between febrile conditions of different origin in hematooncological patients? Ann Hematol 82:98-103
18. Maschmeyer G, Beinert T, Buchheidt D, Einsele H, Heussel CP, Kiehl M, Lorenz J (2003) Diagnosis and antimicrobial therapy of pulmonary infiltrates in febrile neutropenic patients - guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO). Ann Hematol 82(Suppl 2):118-126
19. Zweig MH, Campbell G (1993) Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin Chem 39:561-577
20. Lecharny JB, Khater D, Bronchard R, Philip I, Durand G, Desmonts JM, Dehoux M (2001) Hyperprocalcitonemia in patients with perioperative myocardial infarction after cardiac surgery. Crit Care Med 29:323-325
21. Kettelhack C, Hohenberger P, Schulze G, Kilpert B, Schlag PM (2000) Induction of systemic serum procalcitonin and cardiocirculatory reactions after isolated limb perfusion with recombinant human tumor necrosis factor-alpha and melphalan. Crit Care Med 28:1040-1046
22. Kallio R, Surcel HM, Bloigu A, Syrjala H (2000) C-reactive protein, procalcitonin and interleukin-8 in the primary diagnosis of infections in cancer patients. Eur J Cancer 36:889-894
23. Suzaki H, Asano K, Yu M, Hisamitsu T (2003) Influence of roxithromycin on inflammatory cytokine production from nasal polyp fibroblasts in vitro. Acta Otolaryngol 123:637-642
24. Hirata N, Hiramatsu K, Kishi K, Yamasaki T, Ichimiya T, Nasu M (2001) Pretreatment of mice with clindamycin improves survival of endotoxic shock by modulating the release of inflammatory cytokines. Antimicrob Agents Chemother 45:2638-2642
25. Holzheimer RG (2003) Oral antibiotic prophylaxis can influence the inflammatory response in aortic aneurysm repair: results of a randomized clinical study. J Chemother 15:157-164
26. Wood GC, Boucher BA, Croce MA, Hanes SD, Herring VL, Fabian TC (2002) Aerosolized ceftazidime for prevention of ventilator-associated pneumonia and drug effects on the proinflammatory response in critically ill trauma patients. Pharmacotherapy 22:972-982
27. de Bont ES, Vellenga E, Swaanenburg J, Kamps W (2000) Procalcitonin: a diagnostic marker of bacterial infection in neutropenic cancer patients with fever? Infection 28:398-400
28. Ruokonen E, Nousiainen T, Pulkki K, Takala J (1999) Procalcitonin concentrations in patients with neutropenic fever. Eur J Clin Microbiol Infect Dis 18:283-285